jetprime polyplus cat 114 15 Search Results


jetprimeversatile dna sirna transfection reagent  (Sartorius AG)
99
Sartorius AG jetprimeversatile dna sirna transfection reagent
Jetprimeversatile Dna Sirna Transfection Reagent, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/jetPRIME+DNA%2FsiRNA/pm40066047-136-12-17
Average 99 stars, based on 1 article reviews
jetprimeversatile dna sirna transfection reagent - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
jetprime transfec tion reagent  (Sartorius AG)
99
Sartorius AG jetprime transfec tion reagent
Jetprime Transfec Tion Reagent, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/jetOPTIMUS+DNA+Transfection/pm41614397-120-11-18
Average 99 stars, based on 1 article reviews
jetprime transfec tion reagent - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
jetprime transfection reagent polyplus  (ATCC)
91
ATCC jetprime transfection reagent polyplus
Jetprime Transfection Reagent Polyplus, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/Histoplasma+capsulatum+Darling/pm33338427-203-273-295
Average 91 stars, based on 1 article reviews
jetprime transfection reagent polyplus - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
pcmv cat t7 sb100  (Addgene inc)
96
Addgene inc pcmv cat t7 sb100
Pcmv Cat T7 Sb100, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/pCMV(CAT)T7-SB100+(Plasmid+%2334879)/pmc08595641-394-28-35
Average 96 stars, based on 1 article reviews
pcmv cat t7 sb100 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
pspax2  (Addgene inc)
98
Addgene inc pspax2
Pspax2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/psPAX2+(Plasmid+%2312260)/pm41328592-51-27-28
Average 98 stars, based on 1 article reviews
pspax2 - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier
pmd2 g  (Addgene inc)
98
Addgene inc pmd2 g
Pmd2 G, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/pMD2%2EG+(Plasmid+%2312259)/pm41328592-51-18-19
Average 98 stars, based on 1 article reviews
pmd2 g - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier
interferin sirna/mirna transfection  (Sartorius AG)
99
Sartorius AG interferin sirna/mirna transfection
Interferin Sirna/Mirna Transfection, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/INTERFERin+siRNA%2FmiRNA+transfection/custom%40interferin_sirna_mirna_transfection%4037999979
Average 99 stars, based on 1 article reviews
interferin sirna/mirna transfection - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
nrf2 plasmid  (OriGene)
93
OriGene nrf2 plasmid
Suppression of lenvatinib‐induced ferroptosis by nuclear factor erythroid‐derived 2‐like 2 <t>(Nrf2)</t> in hepatocellular carcinoma (HCC) cells. (A) HCC cells were transfected with siRNA (Nrf2 and control), and Nrf2, phosphorylated Nrf2 (p‐Nrf2), and NADPH quinone oxidoreductase 1 (NQO1) protein levels were assayed via immunoblotting. (B) HCC cells were transfected with siRNA (Nrf2 and control) and treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Malondialdehyde (MDA) levels and cell viability were analyzed. The data are representative of at least three independent experiments. * P < 0.01 versus the control group. (C) HCC cells were treated with ML385, and Nrf2, p‐Nrf2, and NQO1 protein levels were assayed via immunoblotting. HCC cells were treated with ML385 and lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Cell viability was analyzed using the CellTiter‐Glo assay. Hep3B and HuH7 cells were transfected with empty vector or Nrf2 plasmids, and Nrf2 protein levels were assayed via immunoblotting. The transfected cells were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM) or ferrostatin‐1 (fer1, 10 µM). MDA levels were analyzed. Cell viability was analyzed using the CellTiter‐Glo assay. (D) HCC cells transfected with Nrf2 overexpression or control plasmids were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Viability was analyzed using the CellTiter‐Glo assay. Len, lenvatinib
Nrf2 Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/Nrf2+(NFE2L2)+(NM_006164)+Human+Untagged+Clone/pmc09277415-73-1-6
Average 93 stars, based on 1 article reviews
nrf2 plasmid - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
amersham protran nitrocellulose western blot membrane  (Cytiva Europe)
97
Cytiva Europe amersham protran nitrocellulose western blot membrane
Suppression of lenvatinib‐induced ferroptosis by nuclear factor erythroid‐derived 2‐like 2 <t>(Nrf2)</t> in hepatocellular carcinoma (HCC) cells. (A) HCC cells were transfected with siRNA (Nrf2 and control), and Nrf2, phosphorylated Nrf2 (p‐Nrf2), and NADPH quinone oxidoreductase 1 (NQO1) protein levels were assayed via immunoblotting. (B) HCC cells were transfected with siRNA (Nrf2 and control) and treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Malondialdehyde (MDA) levels and cell viability were analyzed. The data are representative of at least three independent experiments. * P < 0.01 versus the control group. (C) HCC cells were treated with ML385, and Nrf2, p‐Nrf2, and NQO1 protein levels were assayed via immunoblotting. HCC cells were treated with ML385 and lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Cell viability was analyzed using the CellTiter‐Glo assay. Hep3B and HuH7 cells were transfected with empty vector or Nrf2 plasmids, and Nrf2 protein levels were assayed via immunoblotting. The transfected cells were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM) or ferrostatin‐1 (fer1, 10 µM). MDA levels were analyzed. Cell viability was analyzed using the CellTiter‐Glo assay. (D) HCC cells transfected with Nrf2 overexpression or control plasmids were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Viability was analyzed using the CellTiter‐Glo assay. Len, lenvatinib
Amersham Protran Nitrocellulose Western Blot Membrane, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/Amersham+Protran+nitrocellulose+Western+blot+membrane/custom%4010600001%4034037855
Average 97 stars, based on 1 article reviews
amersham protran nitrocellulose western blot membrane - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
amersham ecl prime western blot detection reagent  (Cytiva Europe)
98
Cytiva Europe amersham ecl prime western blot detection reagent
Suppression of lenvatinib‐induced ferroptosis by nuclear factor erythroid‐derived 2‐like 2 <t>(Nrf2)</t> in hepatocellular carcinoma (HCC) cells. (A) HCC cells were transfected with siRNA (Nrf2 and control), and Nrf2, phosphorylated Nrf2 (p‐Nrf2), and NADPH quinone oxidoreductase 1 (NQO1) protein levels were assayed via immunoblotting. (B) HCC cells were transfected with siRNA (Nrf2 and control) and treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Malondialdehyde (MDA) levels and cell viability were analyzed. The data are representative of at least three independent experiments. * P < 0.01 versus the control group. (C) HCC cells were treated with ML385, and Nrf2, p‐Nrf2, and NQO1 protein levels were assayed via immunoblotting. HCC cells were treated with ML385 and lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Cell viability was analyzed using the CellTiter‐Glo assay. Hep3B and HuH7 cells were transfected with empty vector or Nrf2 plasmids, and Nrf2 protein levels were assayed via immunoblotting. The transfected cells were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM) or ferrostatin‐1 (fer1, 10 µM). MDA levels were analyzed. Cell viability was analyzed using the CellTiter‐Glo assay. (D) HCC cells transfected with Nrf2 overexpression or control plasmids were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Viability was analyzed using the CellTiter‐Glo assay. Len, lenvatinib
Amersham Ecl Prime Western Blot Detection Reagent, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/Amersham+ECL+Prime+Western+blot+detection+reagent/custom%40rpn2232%4030388410
Average 98 stars, based on 1 article reviews
amersham ecl prime western blot detection reagent - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier
control sirna  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology control sirna
Suppression of lenvatinib‐induced ferroptosis by nuclear factor erythroid‐derived 2‐like 2 <t>(Nrf2)</t> in hepatocellular carcinoma (HCC) cells. (A) HCC cells were transfected with siRNA (Nrf2 and control), and Nrf2, phosphorylated Nrf2 (p‐Nrf2), and NADPH quinone oxidoreductase 1 (NQO1) protein levels were assayed via immunoblotting. (B) HCC cells were transfected with siRNA (Nrf2 and control) and treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Malondialdehyde (MDA) levels and cell viability were analyzed. The data are representative of at least three independent experiments. * P < 0.01 versus the control group. (C) HCC cells were treated with ML385, and Nrf2, p‐Nrf2, and NQO1 protein levels were assayed via immunoblotting. HCC cells were treated with ML385 and lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Cell viability was analyzed using the CellTiter‐Glo assay. Hep3B and HuH7 cells were transfected with empty vector or Nrf2 plasmids, and Nrf2 protein levels were assayed via immunoblotting. The transfected cells were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM) or ferrostatin‐1 (fer1, 10 µM). MDA levels were analyzed. Cell viability was analyzed using the CellTiter‐Glo assay. (D) HCC cells transfected with Nrf2 overexpression or control plasmids were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Viability was analyzed using the CellTiter‐Glo assay. Len, lenvatinib
Control Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/Control+siRNA+(Fluorescein+Conjugate)-A/pmc08025076-60-41-46
Average 96 stars, based on 1 article reviews
control sirna - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
plasmid dna  (Addgene inc)
93
Addgene inc plasmid dna
Suppression of lenvatinib‐induced ferroptosis by nuclear factor erythroid‐derived 2‐like 2 <t>(Nrf2)</t> in hepatocellular carcinoma (HCC) cells. (A) HCC cells were transfected with siRNA (Nrf2 and control), and Nrf2, phosphorylated Nrf2 (p‐Nrf2), and NADPH quinone oxidoreductase 1 (NQO1) protein levels were assayed via immunoblotting. (B) HCC cells were transfected with siRNA (Nrf2 and control) and treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Malondialdehyde (MDA) levels and cell viability were analyzed. The data are representative of at least three independent experiments. * P < 0.01 versus the control group. (C) HCC cells were treated with ML385, and Nrf2, p‐Nrf2, and NQO1 protein levels were assayed via immunoblotting. HCC cells were treated with ML385 and lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Cell viability was analyzed using the CellTiter‐Glo assay. Hep3B and HuH7 cells were transfected with empty vector or Nrf2 plasmids, and Nrf2 protein levels were assayed via immunoblotting. The transfected cells were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM) or ferrostatin‐1 (fer1, 10 µM). MDA levels were analyzed. Cell viability was analyzed using the CellTiter‐Glo assay. (D) HCC cells transfected with Nrf2 overexpression or control plasmids were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Viability was analyzed using the CellTiter‐Glo assay. Len, lenvatinib
Plasmid Dna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jetprime+polyplus+cat+114+15/Klotho+(membrane)+(Plasmid+%2317712)/bio_rxiv__2024__01__18__576116-78-18-20
Average 93 stars, based on 1 article reviews
plasmid dna - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


Suppression of lenvatinib‐induced ferroptosis by nuclear factor erythroid‐derived 2‐like 2 (Nrf2) in hepatocellular carcinoma (HCC) cells. (A) HCC cells were transfected with siRNA (Nrf2 and control), and Nrf2, phosphorylated Nrf2 (p‐Nrf2), and NADPH quinone oxidoreductase 1 (NQO1) protein levels were assayed via immunoblotting. (B) HCC cells were transfected with siRNA (Nrf2 and control) and treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Malondialdehyde (MDA) levels and cell viability were analyzed. The data are representative of at least three independent experiments. * P < 0.01 versus the control group. (C) HCC cells were treated with ML385, and Nrf2, p‐Nrf2, and NQO1 protein levels were assayed via immunoblotting. HCC cells were treated with ML385 and lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Cell viability was analyzed using the CellTiter‐Glo assay. Hep3B and HuH7 cells were transfected with empty vector or Nrf2 plasmids, and Nrf2 protein levels were assayed via immunoblotting. The transfected cells were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM) or ferrostatin‐1 (fer1, 10 µM). MDA levels were analyzed. Cell viability was analyzed using the CellTiter‐Glo assay. (D) HCC cells transfected with Nrf2 overexpression or control plasmids were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Viability was analyzed using the CellTiter‐Glo assay. Len, lenvatinib

Journal: Cancer Science

Article Title: Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma

doi: 10.1111/cas.15378

Figure Lengend Snippet: Suppression of lenvatinib‐induced ferroptosis by nuclear factor erythroid‐derived 2‐like 2 (Nrf2) in hepatocellular carcinoma (HCC) cells. (A) HCC cells were transfected with siRNA (Nrf2 and control), and Nrf2, phosphorylated Nrf2 (p‐Nrf2), and NADPH quinone oxidoreductase 1 (NQO1) protein levels were assayed via immunoblotting. (B) HCC cells were transfected with siRNA (Nrf2 and control) and treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Malondialdehyde (MDA) levels and cell viability were analyzed. The data are representative of at least three independent experiments. * P < 0.01 versus the control group. (C) HCC cells were treated with ML385, and Nrf2, p‐Nrf2, and NQO1 protein levels were assayed via immunoblotting. HCC cells were treated with ML385 and lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Cell viability was analyzed using the CellTiter‐Glo assay. Hep3B and HuH7 cells were transfected with empty vector or Nrf2 plasmids, and Nrf2 protein levels were assayed via immunoblotting. The transfected cells were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM) or ferrostatin‐1 (fer1, 10 µM). MDA levels were analyzed. Cell viability was analyzed using the CellTiter‐Glo assay. (D) HCC cells transfected with Nrf2 overexpression or control plasmids were treated with lenvatinib (HuH7: 0.8 µM, Hep3B: 0.4 µM). Viability was analyzed using the CellTiter‐Glo assay. Len, lenvatinib

Article Snippet: An Nrf2 plasmid (cat. SC116283, NM_006164; Origene) was transfected into HCC cells using a jetPRIME kit (ct. 114, Polyplus Transfection).

Techniques: Derivative Assay, Transfection, Control, Western Blot, Glo Assay, Plasmid Preparation, Over Expression

Regulation of ferroptosis by fibroblast growth factor receptor 4 (FGFR4) and nuclear factor erythroid‐derived 2‐like 2 (Nrf2) in hepatocellular carcinoma. GPX4, glutathione peroxidase 4

Journal: Cancer Science

Article Title: Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma

doi: 10.1111/cas.15378

Figure Lengend Snippet: Regulation of ferroptosis by fibroblast growth factor receptor 4 (FGFR4) and nuclear factor erythroid‐derived 2‐like 2 (Nrf2) in hepatocellular carcinoma. GPX4, glutathione peroxidase 4

Article Snippet: An Nrf2 plasmid (cat. SC116283, NM_006164; Origene) was transfected into HCC cells using a jetPRIME kit (ct. 114, Polyplus Transfection).

Techniques: Derivative Assay